Elthera

Elthera is a privately held biotechnology company headquartered in Switzerland, developing first-class antibodies for the diagnosis and treatment of cancer patients using personalized healthcare approaches. Elthera has obtained an exclusive license from the German Cancer Research Center (DKFZ), Germany's largest biomedical research institution and a leading center in oncology research. Elthera is led by an experienced management team with a proven track record of successfully advancing compounds from research to clinical trials and the market.